Achievements



Research:

  • Screening of Thalassaemia carrier By Nanotechnology based methods.
  • Label Free Characterization for Hematopoietic Stem Cells by Nanotechnology based methods.
  • Development of Spion( super paramagnetic iron oxide nanoparticle) based ferritin sensor.
  • Co-investigator in the project- ‘Gene micromapping of Thalassaemia in West Bengal’.
  • Co-investigator in the project- ‘Study on Aplastic Anemia, Etiological role of environmental and genetic factors in Eastern India funded by WB state DST
  • Clinical Trials- Co investigator of the following clinical trials:
    • a phase 3, randomized, double-blind study of pf-05280586versus rituximab for the first-line treatment of patientswith cd20-positive, low tumor burden, follicular lymphoma.
    • a randomized, double-blind, phase iii study comparing biosimilar rituximab (rtxm83) plus chop chemotherapy versus a reference rituximab plus chop (r-chop) in patients with diffuse large b-cell lymphoma (dlbcl)given as first line
    • a prospective, open-label, multi-centric study to evaluate the efficacy and safety of inj. romiplostim of intas pharmaceuticals ltd. in adult indian patients with chronic refractory idiopathic thrombocytopenic purpura.
    • an open label single arm multicentric study evaluating the safety and efficacy of intranasal methylcobalamin in the treatment and maintainance therapy of vitamin b12 deficiency